메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 23, Issue 19, 2005, Pages 4469-4470
Challenge in the treatment of estrogen-receptor-negative ductal carcinoma in situ [6]
Author keywords

[No Author keywords available]
Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TAMOXIFEN; TRASTUZUMAB; CYCLOOXYGENASE 2; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN;
EID: 22344456705     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.6014     Document Type: Letter
Times cited : (2)
References (6)
  • 1
    • 13744253172 scopus 로고    scopus 로고
    • Prevention of hormone-related cancers: Breast cancer
    • Dunn BK, Wickerham DL, Ford LG: Prevention of hormone-related cancers: Breast cancer. J Clin Oncol 23:357-367, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 357-367
    • Dunn, B.K.1    Wickerham, D.L.2    Ford, L.G.3
  • 2
    • 33846838001 scopus 로고    scopus 로고
    • A prospective study of estrogen and progesterone receptor status in ductal carcinoma-in-situ
    • suppl 1
    • Barnes NLP, Boland G, Davenport A, et al: A prospective study of estrogen and progesterone receptor status in ductal carcinoma-in-situ. Breast Cancer Res Treat 82:534, 2003 (suppl 1)
    • (2003) Breast Cancer Res Treat , vol.82 , pp. 534
    • Barnes, N.L.P.1    Boland, G.2    Davenport, A.3
  • 3
    • 19744371789 scopus 로고    scopus 로고
    • Concordance between estrogen receptor status of ductal carcinoma-in-situ and invasive disease: Analysis of the Surveillance, Epidemiology, and End Results program
    • suppl 1
    • Diab SG: Concordance between estrogen receptor status of ductal carcinoma-in-situ and invasive disease: Analysis of the Surveillance, Epidemiology, and End Results program. Breast Cancer Res Treat 82:S62, 2003 (suppl 1)
    • (2003) Breast Cancer Res Treat , vol.82
    • Diab, S.G.1
  • 4
    • 0037086261 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinomas in situ
    • Half E, Tang XM, Gwyn K, et al: Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinomas in situ. Cancer Res 62:1676-1681, 2002
    • (2002) Cancer Res , vol.62 , pp. 1676-1681
    • Half, E.1    Tang, X.M.2    Gwyn, K.3
  • 5
    • 0037166271 scopus 로고    scopus 로고
    • Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: Evidence for involvement of AP-1 and PEA3
    • Subbaramaiah K, Norton L, Gerald W, et al: Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: Evidence for involvement of AP-1 and PEA3. J Biol Chem 277:18649-18657, 2002
    • (2002) J Biol Chem , vol.277 , pp. 18649-18657
    • Subbaramaiah, K.1    Norton, L.2    Gerald, W.3
  • 6
    • 1342301548 scopus 로고    scopus 로고
    • COX-2 expression is associated with an aggressive phenotype in ductal carcinoma-in-situ
    • Boland GP, Butt IS, Prasad R, et al: COX-2 expression is associated with an aggressive phenotype in ductal carcinoma-in-situ. Br J Cancer 90:423-429, 2004
    • (2004) Br J Cancer , vol.90 , pp. 423-429
    • Boland, G.P.1    Butt, I.S.2    Prasad, R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.